0000950170-23-056496.txt : 20231030
0000950170-23-056496.hdr.sgml : 20231030
20231030194244
ACCESSION NUMBER: 0000950170-23-056496
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231026
FILED AS OF DATE: 20231030
DATE AS OF CHANGE: 20231030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cashman Neil
CENTRAL INDEX KEY: 0001927064
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41429
FILM NUMBER: 231361953
MAIL ADDRESS:
STREET 1: C/O PROMIS NEUROSCIENCES INC.
STREET 2: SUITE 200, 1920 YONGE STREET
CITY: TORONTO
STATE: A6
ZIP: M4S 3E2
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProMIS Neurosciences Inc.
CENTRAL INDEX KEY: 0001374339
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 200, 1920 YONGE STREET
CITY: TORONTO
STATE: A6
ZIP: M4S 3E2
BUSINESS PHONE: 416-847-6898
MAIL ADDRESS:
STREET 1: SUITE 200, 1920 YONGE STREET
CITY: TORONTO
STATE: A6
ZIP: M4S 3E2
FORMER COMPANY:
FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD
DATE OF NAME CHANGE: 20060831
4
1
ownership.xml
4
X0508
4
2023-10-26
0001374339
ProMIS Neurosciences Inc.
PMN
0001927064
Cashman Neil
C/O PROMIS NEUROSCIENCES INC.,1920 YONGE
STREET, SUITE 200
TORONTO
A6
M4S 3E2
ONTARIO, CANADA
true
true
false
false
Chief Scientific Officer
false
Option (right to buy)
1.87
2023-10-26
4
A
false
12500
0
A
2033-10-26
Common Shares
12500
12500
D
25% of the shares subject to this option shall vest on October 26, 2024, and the balance shall vest ratably over 36 months.
/s/ Max A. Milbury, Attorney-in-Fact for Neil Cashman
2023-10-30